T-Net: Home

Member Login
|
Employer Login

BC Tech News ▼
International ▼
Member Tools ▼
- Subscribe to T-Net Direct
Submit News ▼

« Sections »
News
Events
Tech Careers
Directory
Tech Stocks
T-Net 100
Members
Feedback
About T-Net
« Account Login »
Members
Employers
« Services »
Post Job Listings
Browse Jobs
Advertise

News By Company

Aurinia Pharmaceuticals Inc.

1 - 10 of 42 Results

New Search

Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights

Victoria, BC, August 10, 2021--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) issued its financial results for the second quarter ended June 30, 2021.As of June 30, 2021, Aurinia had cash and cash equivalents and investments of $323.7 million compared to $422.7 million at December 31, 2020. For the quarter ended June 30, 2021, Aurinia recorded a net loss of $47.0 million or $0.37 net loss per common share.

Snapshot | Profile | News (48) | Follow

Company Snapshot

Aurinia Pharmaceuticals Inc.

Victoria (Biotech/Life Sciences)
20-49 Employees In BC (20-49 Employees Total)
Founded: 2013

Aurinia is a late-stage biopharmaceutical company providing novel products specifically engineered to treat a limited, targeted patient population suffering from serious disease states for which there is a high unmet medical need

See Full Profile

Company Alert

Aurinia Pharmaceuticals Inc.

Victoria (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Victoria-based Biopharmaceutical Company Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange (Maintains Nasdaq Listing)

Victoria, BC, July 20, 2021--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company), a commercial stage biopharmaceutical company advancing therapies for severe autoimmune diseases, announced it will voluntarily delist the common shares of the Company from the Toronto Stock Exchange (TSX) effective as of the close of trading on July 30, 2021.

Snapshot | Profile | News (48) | Follow

Company Snapshot

See Full Profile

Company Alert

Aurinia Pharmaceuticals Inc.

Victoria (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application for Voclosporin with the European Medicines Agency

Victoria, BC, July 6, 2021--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) announced that the Company's licensing partner, Otsuka Pharmaceutical Europe Ltd. (OPEL), filed an initial Marketing Authorization Application (MAA) for voclosporin for the treatment of lupus nephritis (LN) to the European Medicines Agency (EMA).

Snapshot | Profile | News (48) | Follow

Company Snapshot

See Full Profile

Company Alert

Aurinia Pharmaceuticals Inc.

Victoria (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors

Victoria, BC, June 21, 2021--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company) announced the appointment of Dr. Brinda Balakrishnan, M.D., Ph.D., to the Company's Board of Directors. Dr. Balakrishnan is Group Vice President, Corporate and Business Development of BioMarin Pharmaceutical Inc., a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare disorders.

Snapshot | Profile | News (48) | Follow

Company Snapshot

See Full Profile

Company Alert

Aurinia Pharmaceuticals Inc.

Victoria (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights

Victoria, BC, May 17, 2021--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) issued its financial results for the first quarter ended March 31, 2021. The company reported cash and cash equivalents, and investments of $360.9 million US at March 31, 2021.

Snapshot | Profile | News (48) | Follow

Company Snapshot

See Full Profile

Company Alert

Aurinia Pharmaceuticals Inc.

Victoria (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights (Reports Cash Liquidity of US $423M)

Victoria, BC, March 3, 2021--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) issued its financial results for the fourth quarter and year ended December 31, 2020. Amounts, unless specified otherwise, are expressed in U.S. dollars.

Snapshot | Profile | News (48) | Follow

Company Snapshot

See Full Profile

Company Alert

Aurinia Pharmaceuticals Inc.

Victoria (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Victoria-based Aurinia Announces U.S. FDA Approval for its LUPKYNIS Therapy for Adult Patients with Active Lupus Nephritis - Stock Soars 26%

Victoria, BC, January 26, 2021--Aurinia Announces U.S. FDA Approval for its LUPKYNIS™ (voclosporin) Therapy for Adult Patients with Active Lupus Nephritis - Stock Soars 26%

Snapshot | Profile | News (48) | Follow

Company Snapshot

See Full Profile

Company Alert

Aurinia Pharmaceuticals Inc.

Victoria (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity

Victoria, BC, December 31, 2020--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) and Lonza Ltd. (SIX: LONN) announced they have expanded their exclusive manufacturing relationship. The parties entered into a collaborative agreement to build a dedicated manufacturing capacity within Lonza's existing small molecule API facility in Visp, Switzerland.

Snapshot | Profile | News (48) | Follow

Company Snapshot

See Full Profile

Company Alert

Aurinia Pharmaceuticals Inc.

Victoria (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Aurinia Receives Upfront Payment of U.S. $50 Million for Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co.

Victoria, BC, December 29, 2020--Aurinia Receives Upfront Payment of U.S. $50 Million for Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosp

Snapshot | Profile | News (48) | Follow

Company Snapshot

See Full Profile

Company Alert

Aurinia Pharmaceuticals Inc.

Victoria (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

Victoria, BC-based Aurinia Pharmaceuticals Announces Outcome of AUDREY Clinical Trial in Dry Eye Syndrome

Victoria, BC, November 10, 2020--Aurinia Pharmaceuticals Inc.(Nasdaq: AUPH / TSX:AUP), a late-stage clinical biopharmaceutical company, announced topline data from the Phase 2/3 AUDREY™ clinical study evaluating voclosporin ophthalmic solution (VOS) for the potential treatment of dry eye syndrome (DES).

Snapshot | Profile | News (48) | Follow

Company Snapshot

See Full Profile

Company Alert

Aurinia Pharmaceuticals Inc.

Victoria (Biotech/Life Sciences)

Notify Me

New Job Listings Posted By This Company
News and Editorial Regarding This Company
Company Profile Changes and Updates
Personnel Changes At This Company

Company Alert Notification Settings

Please select how you would like to be notified of updates by this Company:

	Display Updates For This Company in My Member Account Online
	Please Send me an Email Alert (With All of My Company Updates) On The Following Dates:
	(Updates from all selected companies are combined and sent in a single email)

Cancel

1 2 3 4 5

Hiring Today

See All Jobs

Latest Tech Jobs

Featured Job: Senior Embedded Software Engineer

Damon Motors Inc.

Full Stack Developer

Rimex Supply Ltd

Full Stack Developer

BC Public Service

Lead, Business Analysis (Robotic Process Automation - RPA)

Interior Health Authority

Marketing Communications Specialist

General Fusion Inc.

See All Jobs

Registration on or use of this website constitutes acceptance of our Terms of Use.

News
BC Tech News ▼
- Local BC Tech News
- One Week View
- Subscribe to T-Net Direct
International ▼
- All Breaking International Tech News
- Tech Crunch
- Silicon Alley Insider
- VentureBeat
- CNET
Member Tools ▼
- Subscribe to T-Net Direct
Submit News ▼
- Post News Release on T-Net
- Submit Anonymous News Tip
- T-Net News Submission Guidelines
Account
Member Login
Employer Login
Sections
News
- BC Tech News ▼
- International ▼
- Member Tools ▼
  - Subscribe to T-Net Direct
- Submit News ▼
Events
- All BC Tech Events ▼
- Member Tools ▼
- Post Events ▼
Tech Careers
- Tech Careers Home
- Job Search ▼
- Hot Job of the Week TM
- Post Resume ▼
  - Post Resume
  - Create Cover Letter
- Member Tools ▼
- Employers ▼
  - Employer Login
  - Post New Job
Directory
- Tech Directory Home
- Companies ▼
- Suppliers ▼
- Associations ▼
- Add Profile ▼
Tech Stocks
- BC Tech Stocks ▼
- T-Net 20 Stock Index
- Member Tools ▼
  - Stock Alerts
  - Company Search
- Add Company ▼
  - Add Company
T-Net 100
- T-Net 100 Rankings ▼
- Sector Rankings ▼
- Advertising
Members
- Member Home ▼
- News ▼
- Events ▼
- Careers ▼
- Directory ▼
- Other ▼
Feedback
About T-Net
Services
Post Job Listings
Advertise on T-Net